Atropine approval: What does it mean for the management of myopia?
Update: 2025-12-10
Description
College Clinical Advisers Denise Voon MCOptom, Dr Paramdeep Bilkhu MCOptom, and Daniel Hardiman-McCartney FCOptom MBE discuss the recent news from the Medicines and Healthcare products Regulatory Agency (MHRA) approving the first low-dose atropine treatment for myopia in the UK.
They talk about what the news means for optometrists and answer questions from College members.
Further information
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
